Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Steiner

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|October 23, 2003
The need for a different cholesterol lowering drugGeorge Steiner
Endocrinology and Metabolism Clinics of North America|July 21, 2004
Fibrates in the metabolic syndrome and in diabetesGeorge Steiner
Current Opinion in Lipidology|October 30, 2008
Lipid lowering in the patients with prediabetes/metabolic syndrome: what is the evidence?George Steiner
Diabetes & Vascular Disease Research|December 26, 2007
Atherosclerosis in type 2 diabetes: a role for fibrate therapy?George Steiner
Cardiovascular Drugs and Therapy|September 17, 2009
How can we improve the management of vascular risk in type 2 diabetes: insights from FIELDGeorge Steiner
Atherosclerosis|May 17, 2005
Fibrates and coronary risk reductionGeorge Steiner
The American Journal of Cardiology|December 17, 2008
Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitusGeorge Steiner
Treatments in Endocrinology|September 28, 2005
A new perspective in the treatment of dyslipidemia : can fenofibrate offer unique benefits in the treatment of type 2 diabetes mellitus?George Steiner
The American Journal of Cardiology|July 4, 2006
Statement of the problemGeorge Steiner,
Seminars in Arthritis and Rheumatism|April 9, 2008
Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatmentGeorge Steiner, Murray B Urowitz
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|October 23, 2003
The need for a different cholesterol lowering drugGeorge Steiner
Endocrinology and Metabolism Clinics of North America|July 21, 2004
Fibrates in the metabolic syndrome and in diabetesGeorge Steiner
Current Opinion in Lipidology|October 30, 2008
Lipid lowering in the patients with prediabetes/metabolic syndrome: what is the evidence?George Steiner
Diabetes & Vascular Disease Research|December 26, 2007
Atherosclerosis in type 2 diabetes: a role for fibrate therapy?George Steiner
Cardiovascular Drugs and Therapy|September 17, 2009
How can we improve the management of vascular risk in type 2 diabetes: insights from FIELDGeorge Steiner
Atherosclerosis|May 17, 2005
Fibrates and coronary risk reductionGeorge Steiner
The American Journal of Cardiology|December 17, 2008
Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitusGeorge Steiner
Treatments in Endocrinology|September 28, 2005
A new perspective in the treatment of dyslipidemia : can fenofibrate offer unique benefits in the treatment of type 2 diabetes mellitus?George Steiner
The American Journal of Cardiology|July 4, 2006
Statement of the problemGeorge Steiner,
Seminars in Arthritis and Rheumatism|April 9, 2008
Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatmentGeorge Steiner, Murray B Urowitz
Pageof 3